-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/factsheets/translating/action3/actioniii-2016-summaries-revised.pdf
January 01, 2016 - The 10 HACs being studied are:
• Adverse drug events (anticoagulants, opioids, and hypoglycemic agents
-
www.ahrq.gov/sites/default/files/2024-11/gershon-report.pdf
January 01, 2024 - Incidence and Preventability of Adverse Drug Events in Hospitalized Adults.
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-5-working-with-safety-net-practices.pdf
September 01, 2015 - Pharmacy students review the warfarin registry to look for drug interactions, patients who may
be missing
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/mvp/modules/technical/daily-care-processes-guide.pdf
January 01, 2017 - Daily Care Processes Guide for Reducing Ventilator-Associated Events in Mechanically Ventilated Patients
AHRQ Safety Program for
Mechanically Ventilated Patients
Daily Care Processes Guide for Reducing
Ventilator-Associated Events in
Mechanically Ventilated Patients
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-fullreport.pdf
January 01, 2020 - Ratio of Magnetic Resonance Imaging Scans to Computed Tomography Scans for the Evaluation of Children with Atraumatic Headache
1
Ratio of Magnetic Resonance Imaging Scans to
Computed Tomography Scans for the Evaluation of
Children with Atraumatic Headache
Section 1. Basic Measure Information
1.A. Measure N…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - CHIPRA 194: Overuse of Imaging for the Evaluation of Children With Primary Headache Report
1
Overuse of Imaging for the Evaluation of Children with
Primary Headache
Section 1. Basic Measure Information
1.A. Measure Name
Overuse of Imaging for the Evaluation of Children with Primary Headache
1.B. Measure Numbe…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/tools/perinatal-care/frontline-cases-studies.pdf
May 01, 2015 - A unit nurse explained, “It’s a dangerous
drug that we need to be respectful of, so having a plan and
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/events/webinars/cahps-moving-forward-webcast.pdf
October 01, 2017 - There are three
variants of the survey: radiation therapy, drug therapy and surgery.
-
www.ahrq.gov/sites/default/files/2025-03/isbell-boudreaux-report.pdf
January 01, 2025 - Behavioral Health Trends in the United
States: Results from the 2014 National Survey on Drug Use and
-
www.ahrq.gov/sites/default/files/wysiwyg/diagnostic/resources/issue-briefs/dx-safety-rural-healthcare.pdf
July 01, 2024 - Diagnostic Excellence in U.S. Rural Healthcare: A Call to Action
PATIENT
SAFETY
e
Issue Brief 22
re
ostic
Safety in Older Adults
Issue Brief 24
Diagnostic Excellence in U.S. Rural
Healthcare: A Call to Action
PATIENT
SAFETY
e
This page intentionally left blank.
e
Issue Brief 24
Diagnostic Excelle…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/prevhosp/prevhospitalvisits-funcspecs_0.pdf
August 01, 2017 - On-Time Preventable Hospital and ED Visits Functional Specs
AHRQ’s Safety Program for Nursing Homes:
On-Time Preventable Hospital and Emergency
Department Visits
Functional Specifications
Current as of August 2017
Contents
1. General Information .......…
-
www.ahrq.gov/sites/default/files/wysiwyg/chsp/compendium/2023-compendium-techdoc.pdf
January 01, 2023 - In addition, IQVIA uses Drug Distribution Data that enable quick identification of new
organizations … ’s National Plan and Provider
Enumeration System (NPPES), State Controlled Substance Registration, Drug
-
www.ahrq.gov/patient-safety/reports/issue-briefs/dxsafety-current-state-references.html
January 01, 2024 - Diagnostic error as a result of drug-laboratory test interactions.
-
www.ahrq.gov/diagnostic-safety/resources/issue-briefs/dxsafety-current-state-references.html
January 01, 2024 - Diagnostic error as a result of drug-laboratory test interactions.
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/about/2013cliniciangroupchartbook.pdf
July 01, 2014 - you and anyone in this provider’s office talk
about a personal problem, family problem, alcohol use, drug
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-169-gestational-age-additional-specifications.pdf
January 01, 2012 - FFS
PHDSC 2.16.840.1.113883.221.5 Payer Individual Characteristic Source of Payment Typology 4.0 122 Drug
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/2013_cg_cahps_chartbook.pdf
January 01, 2013 - you and anyone in this provider’s office talk
about a personal problem, family problem, alcohol use, drug
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0082cesareancoding.xls
January 01, 2012 - FFS
PHDSC 2.16.840.1.113883.221.5 Payer Individual Characteristic Source of Payment Typology 4.0 122 Drug
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/tools/literacy-toolkit/impguide/healthlit-guide.pdf
January 01, 2015 - clinicians to consider whether a generic is a suitable substitute for a name brand or newer
version of the drug
-
www.ahrq.gov/sites/default/files/publications/files/healthlit-guide_3.pdf
January 01, 2015 - clinicians to consider whether a generic is a suitable substitute for a name brand or newer
version of the drug